Novartis Failed to Warn the American Medical Community of the Side Effects of Tasigna

Tasigna has been found to cause atherosclerosis and peripheral artery disease in cancer patients being treated with the deadly anti-cancer chemotherapy drug

Friday, September 1, 2017 - St. Louis based Onder Law PLC, represent the victims of negligent on the part of pharmaceutical companies such as Novartis AG and who are suffering from atherosclerosis and peripheral artery disease as a result of taking the popular anti-cancer drug Tasigna.

If you are suffering from the advanced stages of chronic myeloid leukemia, chances are you have been given Tasigna chemotherapy treatment and you may have developed serious side effects such as atherosclerosis which is the narrowing and hardening of the arteries due to the build-up of plaque and white blood cells. If left untreated, atherosclerosis can require a leg or foot to be amputated, cause a heart attack, and a stroke, the result of which could be sudden death.

In addition to atherosclerosis, another deadly side effect of Tasigna is peripheral artery disease (PAD), described by the highly acclaimed National Institute of Health as "a disease in which plaque, cholesterol, calcium, fibrous tissue, and other substances, builds up in the arteries that carry blood to your head, organs, and limbs. PAD affects approximately 10 million people and can be treated but is irreversible. Peripheral artery disease can be diagnosed by contrasting the blood pressure in the arm versus the blood pressure in the leg. Major arteries leading to the legs are the most common location of PAD blockages and the resultant decreased blood flow. Restricted blood flow to the extremities of the feet and toes can lead to gangrene to set in requiring amputation.

People given the anti-cancer chemotherapy drug Tasigna should be alerted for the early warning symptoms of peripheral artery disease. Pain, cramping, numbness, and tingling in the fingers, toes, and feet during and after walking or climbing stairs could indicate the onset of PAD. Aching in the thighs, hips, calfs, and arms while at rest are other symptoms to watch for. Ignoring the early symptoms of PAD can lead to painful lesions on the feet, arms, hands, and legs that do not heal normally, body hair loss, toenail and skin yellowing and erectile dysfunction in men.

Evidence presented in Tasigna lawsuits allege that the maker of Tasigna, Novartis AG Pharmaceutical was aware of the link between Tasigna and atherosclerosis/PAD as early as 2011 and for five years did nothing to alert cancer physicians in America. In the spring of 2013, Health Canada published a stern Tasigna warning linking its usage to atherosclerosis yet failed to warn the American medical community, cancer doctors, pharmacists, health officials and more importantly, the American public. Lawsuits allege the symptoms of atherosclerosis/PAD were non-existent in chemotherapy patients until physicians switched from Gleevec, a perfectly adequate form of chemotherapy to the more profitable drug Tasigna by the use of sales pressure, cash kickbacks, phony teaching schemes, and bribery from Novartis corporate executives. Novartis failed to update their Canadian Tasigna packaging for years while collecting hundreds of millions in sales of the drug before finally warning the Canadian public in 2013. The American public was never warned.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.